Rocket Doctor AI tops 53,000 visits in Q3 and expects record revenue

Rocket Doctor AI said it completed 53,348 patient visits in the third quarter of 2026 across the U.S. and Canada and expects record quarterly revenue. The results point to faster growth in its U.S. business, though revenue recognition still lags patient volume because of claims processing and cash collection timing.

Why it matters: - Rocket Doctor AI is showing faster operating scale in North America, with U.S. volume growth that could flow into revenue later. - The company said the quarter’s visit growth is an indicator of broader financial momentum as collections catch up with clinical activity.

What happened: - Rocket Doctor AI said it completed 53,348 patient visits in Q3 2026 across the U.S. and Canada. - U.S. visits totaled 6,101, up 56% from 3,911 in Q2 2026. - Canadian visits totaled 47,247, up 24% from 37,960 in Q3 2025. - The company said it expects to report record quarterly revenue for Q3 2026. - The update covers the quarter ended Sept. 30, 2026.

The details: - U.S. clinical hours reached 2,634 in Q3, up 33% from 1,987.5 in Q2 2026. - Rocket Doctor AI said the U.S. growth reflects execution of its multi-payer strategy in key state markets. - The company said it now has more than 20 in-network payer agreements across commercial, Medicare Advantage and Medicaid segments. - Rocket Doctor AI said final quarterly U.S. visit volumes exceeded the preliminary indicators it shared in a Sept. 14 operational update. - The company said some U.S. revenues are recognized on a cash basis, creating a lag between patient visits and reported revenue. - For out-of-network U.S. patients, Rocket Doctor AI said reimbursement is generally not expected, but claims may still be submitted where possible. - Any amounts recovered from out-of-network claims are recognized only when cash is received. - Rocket Doctor AI said it continues to evaluate network coverage and payer relationships to convert more patients and physicians to in-network status. - The company said its Global Library of Medicine is a clinically validated decision support system developed with input from hundreds of physicians worldwide. - Rocket Doctor AI said its technology has helped empower over 350 MDs to provide care for more than 800,000 patient visits. - The company said it aims to support underserved, rural and remote communities in Canada and patients on Medicaid and Medicare in the United States. - The release included a link to the company profile at the company's in-depth profile. - The release also pointed readers to the full publisher network page. - Rocket Doctor AI directed readers to the company website and the email address info@rocketdoctor.ai for more information.

Between the lines: - The revenue outlook hinges on how quickly the company can convert visit volume into collected cash, especially in the U.S. market. - The 56% quarterly jump in U.S. visits suggests the network and payer strategy is scaling faster than revenue may appear in reported results right away. - The company’s focus on in-network coverage signals a push for more predictable reimbursement and less collection uncertainty.

What's next: - Rocket Doctor AI said management will continue working to expand payor relationships and convert out-of-network users to in-network status over time. - The company expects those changes to improve reimbursement rates and increase revenue visibility going forward. - Investors will be watching the company’s Q3 2026 financial results for confirmation of the record revenue outlook.

The bottom line: - Rocket Doctor AI is growing visits quickly, but the payoff in reported revenue depends on how fast billing and collections catch up.